Leydig Voit & Mayer Attorneys Comment On Principal Issues In U.S. Patent Infringement Suits
October 13, 2009Two members of Leydig, Voit & Mayer will present comments on U.S. patent infringement suits in a mock trial presentation format in Osaka, Japan, on November 16 in conjunction with Chuo Sogo Law Office, P.C.
Leydig's members, John Kilyk, Jr. (Chicago office), and Jeremy M. Jay (Washington, D.C. office), team up with Naoko Nakatsukasa and Masao Kuniyoshi of Chuo Sogo for the mock trial presentation. The seminar also will include a presentation on U.S. patent application practice and licensing with overseas affiliates and transfer pricing taxation.
John Kilyk practices law exclusively in the field of intellectual property, including patent interference, opposition, legal opinion, prosecution, and litigation matters, with specific concentration in the areas of biotechnology, chemistry, and pharmaceuticals. Recent technologies with which he has been involved include new chemical compounds, nucleic acid sequences, proteins, chemical and biological assays, monoclonal antibodies, cell lines, DNA cloning and amplification techniques, genetic vectors, medical treatments, pharmaceutical compositions, polymeric membranes, chemical syntheses, enzymatic reactions, and chemical surface treatments.
With extensive experience in formulating patent strategies and in managing patent portfolios, Mr. Kilyk counsels and renders opinions on patent validity, patent infringement, technology licensing, and the protection of trade secrets and other proprietary information. He also prepares and prosecutes patent applications in the U.S. and foreign countries, as both independent activities and as part of coordinated overall patent strategies on behalf of clients. He has been instrumental in securing patent protection for breakthrough technologies in the U.S. and internationally.
Jeremy Jay practices law exclusively in the field of intellectual property. He is active in U.S. and foreign patent prosecution, and foreign patent oppositions, with particular emphasis in the areas of biotechnology, biomedicine, chemistry, and the mechanical arts. Recent technologies with which he has been involved include cloning and amplification techniques, recombinant antibodies, nucleic acid sequences, proteins, disease detection assays, medical treatments, blood filters, and polymeric membranes.
Dr. Jay has extensive experience in managing patent portfolios, counseling, and rendering opinions for U.S. and foreign clients on inventorship, patent validity and infringement issues in a variety of technical fields. He has considerable experience in patent oppositions in Europe.
About Leydig, Voit & Mayer
For more than a century, Leydig, Voit & Mayer, Ltd., has assisted clients - from large corporations to individual inventors - with intellectual property litigation, counseling, licensing, and prosecution services worldwide. The firm prides itself on its ability to meet the most demanding intellectual property needs of its clients.
